| Related Articles |
Oral administration of methylphenidate (Ritalin) differentially affects dopamine release between the prefrontal cortex and striatum – a microdialysis study in the monkey.
J Neurosci. 2017 Feb 02;:
Authors: Kodama T, Kojima T, Honda Y, Hosokawa T, Tsutsui KI, Watanabe M
Abstract
Methylphenidate (MPH: Ritalin) is a widely used drug for the treatment of attention deficit hyperactivity disorder (ADHD), and is often used as a cognitive enhancer. Since MPH increases dopamine (DA) release by blocking the DA transporter in the human striatum, MPH is supposed to work on attention and cognition through a DA increase in the striatum. However, ADHD patients show impaired prefrontal cortex (PFC) function, and MPH administration is associated with increased neural activity in the PFC. Although MPH is indicated to increase DA release in the rat PFC, there has been no study to examine MPH-induced DA changes in the human PFC because of technical difficulties associated with the low level of PFC DA receptors. Utilizing the microdialysis technique, we examined the effects of oral administration of MPH on DA release in both the PFC and striatum in the monkey. We also tested the effect of MPH on cognitive task performance. As in human studies, in the striatum, both high and low doses of MPH induced consistent increases in DA release about 30 min after their administrations. In the PFC, a consistent increase in DA release was observed 1 h after a high dose of, but not low doses of MPH administration. Low doses of MPH improved cognitive task performance, but a high dose of MPH made the monkey drowsy. Thus, low doses of MPH-induced cognitive enhancement is supposed to be supported by the striatum DA increase.
SIGNIFICANT STATEMENT: Methylphenidate (MPH) is a widely used drug for the treatment of attention deficit hyperactivity disorder (ADHD), and is often used as a cognitive enhancer. Although human positron emission tomography studies suggest that MPH works on attention and cognition through DA changes in the striatum, there has been no study to examine MPH-induced DA changes in the human PFC. Utilizing the microdialysis technique on monkeys, we, for the first time, found that low doses of MPH consistently increased DA release in the striatum, while they did not in the PFC. Cognitive enhancement effects of low doses of MPH are supposed to be supported by the striatum DA increase.
PMID: 28154152 [PubMed – as supplied by publisher]
via https://www.ncbi.nlm.nih.gov/pubmed/28154152?dopt=Abstract
